DOI:
10.1055/s-00000030
Der Klinikarzt
LinksClose Window
References
Levy-Clarke G, Jabs DA, Read RW. et al
Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders.
Ophthalmology 2014;
121: 785-796.e3
We do not assume any responsibility for the contents of the web pages of other providers.